Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The human pregnancy-specific glycoproteins (PSGs) are a family of proteins that are synthesized in large amounts by placental trophoblasts and released into the maternal circulation during pregnancy.
Showing 6 out of 8 products:
Integrating the dual-signal amplification strategy, a novel 3D origami electrochemical immunodevice for simultaneous detecting carcinoembryonic antigen (CEA (show CEACAM5 Proteins)) and cancer antigen 125 (CA125 (show MUC16 Proteins))
the authors evaluated the prognostic significance of the CEA (show CEACAM5 Proteins) and CA-19.9 serum tumor markers in advanced (unresectable) pancreatic cancer
This genetic cancer vaccineis highly immunogenic and can break tolerance to CEA (show CEACAM5 Proteins) tumor antigen in CEA (show CEACAM5 Proteins) transgenic mice.
The human pregnancy-specific glycoproteins (PSGs) are a family of proteins that are synthesized in large amounts by placental trophoblasts and released into the maternal circulation during pregnancy. Molecular cloning and analysis of several PSG genes has indicated that the PSGs form a subgroup of the carcinoembryonic antigen (CEA) gene family, which belongs to the immunoglobulin superfamily of genes. Members of the CEA family consist of a single N domain, with structural similarity to the immunoglobulin variable domains, followed by a variable number of immunoglobulin constant-like A and/or B domains. Most PSGs have an arg-gly-asp (RGD) motif, which has been shown to function as an adhesion recognition signal for several integrins, in the N-terminal domain (summary by Teglund et al., 1994
, carcinoembryonic antigen SG8
, pregnancy-specific beta-1 glycoprotein E
, pregnancy-specific beta-1-glycoprotein 2
, pregnancy-specific beta-1-glycoprotein 7
, pregnancy-specific beta-1-glycoprotein-2
, pregnancy-specific glycoprotein 2